Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. It also provides second opinion consultation and health care decision support services. The company serves employers who provide their employees and their employees' families a single place to turn for their health, healthcare, and benefits needs. Accolade, Inc. was incorporated in 2007 and is headquartered in Plymouth Meeting, Pennsylvania.
P/E ratio for Accolade, Inc. (ACCD)
P/E ratio as of 2024: -7.69
According to Accolade, Inc.'s latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -7.69. At the end of 2023 the company had a P/E ratio of -1.72.
P/E ratio history for Accolade, Inc. from 2018 to 2024
PE ratio at the end of each year
| Year | P/E ratio |
|---|---|
| 2024 | -7.69 |
| 2023 | -1.72 |
| 2022 | -9.32 |
| 2021 | -27.30 |
| 2020 | -0.52 |
| 2019 | -0.34 |
| 2018 | -0.31 |